ZURICH, Sept 22 (Reuters) - Sandoz, the generic drugs unit of Novartis, has lost World Health Organisation approval for drugs produced at a South African plant due to manufacturing problems, the U.N. agency said on Monday.
ZURICH, Sept 22 (Reuters) - Sandoz, the generic drugs unit of Novartis, has lost World Health Organisation approval for drugs produced at a South African plant due to manufacturing problems, the U.N. agency said on Monday.
